UBS slashes target price on Novo Nordisk, citing compounders, Eli Lilly threat

marketwatch.com/bulletins/redirect/go?g=22ec49a8-91e1-4b0e-acba-cfa0e4ea4c8a

This story appeared on marketwatch.com, 2025-08-05 09:27:07.
The Entire Business World on a Single Page. Free to Use →